Clinical Trials
8
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
- Conditions
- Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency
- Interventions
- First Posted Date
- 2021-01-12
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Medicure
- Target Recruit Count
- 15
- Registration Number
- NCT04706013
- Locations
- 🇺🇸
Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸Lucile Packard Children's Hospital, Palo Alto, California, United States
🇺🇸Boston Children's Hospital, Boston, Massachusetts, United States
Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function
- First Posted Date
- 2013-01-11
- Last Posted Date
- 2014-03-27
- Lead Sponsor
- Medicure
- Target Recruit Count
- 25
- Registration Number
- NCT01766154
- Locations
- 🇺🇸
Avail Clinical Research, LLC, DeLand, Florida, United States
Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
- Conditions
- Myocardial InfarctionAcute Coronary SyndromesUnstable Angina
- Interventions
- First Posted Date
- 2012-01-31
- Last Posted Date
- 2021-05-13
- Lead Sponsor
- Medicure
- Target Recruit Count
- 535
- Registration Number
- NCT01522417
- Locations
- 🇺🇸
Osceola Regional Medical Center, Kissimmee, Florida, United States
🇺🇸Northside Hospital, Saint Petersburg, Florida, United States
🇺🇸Emory University Hospital Midtown, Atlanta, Georgia, United States
Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention
- Conditions
- Myocardial InfarctionUnstable AnginaPercutaneous Coronary InterventionAcute Coronary Syndromes
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-11-22
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- Medicure
- Registration Number
- NCT01245725
Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
- First Posted Date
- 2009-06-10
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Medicure
- Target Recruit Count
- 53
- Registration Number
- NCT00917293
- Locations
- 🇨🇦
Vancouver Island Health Authority, Victoria, British Columbia, Canada
🇨🇦Centre for Addiction and Mental Health, Toronto, Ontario, Canada
🇨🇦Windsor Regional Hospital, Windsor, Ontario, Canada
- Prev
- 1
- 2
- Next